Lantern Pharma Analyst Ratings
Lantern Pharma Analyst Ratings
While ratings are subjective and will change, the latest Lantern Pharma (LTRN) rating was a maintained with a price target of $0.00 to $11.00. The current price Lantern Pharma (LTRN) is trading at is $5.22, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/15/2023 | 110.61% | EF Hutton | → $11 | Maintains | Buy |
| 11/01/2022 | 110.61% | EF Hutton | → $11 | Initiates Coverage On | → Buy |
| 03/11/2022 | 589.26% | HC Wainwright & Co. | $34 → $36 | Maintains | Buy |
| 11/02/2021 | 550.97% | HC Wainwright & Co. | $32 → $34 | Maintains | Buy |
| 10/07/2021 | 512.67% | HC Wainwright & Co. | → $32 | Initiates Coverage On | → Buy |
| 07/28/2020 | 359.51% | Colliers Securities | → $24 | Initiates Coverage On | → Buy |
| 日期 | 上/下行 | 分析師公司 | 价格目標變更 | 評級變更 | 上一頁/目前評分 |
|---|---|---|---|---|---|
| 02/15/2023 | 110.61% | EF 赫頓 | → 11 美元 | 維護 | 購買 |
| 11/01/2022 | 110.61% | EF 赫頓 | → 11 美元 | 啟動覆蓋範圍 | → 購買 |
| 03/11/2022 | 589.26% | HC 溫賴特 & 有限公司. | 三十四美元 → 三十六美元 | 維護 | 購買 |
| 11/02/2021 | 550.97% | HC 溫賴特 & 有限公司. | 三二元 → 三十四美元 | 維護 | 購買 |
| 2021 年 7 月 10 日 | 512.67% | HC 溫賴特 & 有限公司. | → 三十二美元 | 啟動覆蓋範圍 | → 購買 |
| 07/28/2020 | 359.51% | 高力國際證券 | → 二十四美元 | 啟動覆蓋範圍 | → 購買 |
What is the target price for Lantern Pharma (LTRN)?
燈籠製藥（LTRN）的目標價格是多少？
The latest price target for Lantern Pharma (NASDAQ: LTRN) was reported by EF Hutton on February 15, 2023. The analyst firm set a price target for $11.00 expecting LTRN to rise to within 12 months (a possible 110.61% upside). 3 analyst firms have reported ratings in the last year.
EF 赫頓於 2023 年 2 月 15 日報導了燈籠製藥（納斯達克股票代碼：LTRN）的最新價格目標。該分析師公司將價格目標設定為 11.00 美元，預計 LTRN 將在 12 個月內上升（可能是 110.61％ 的上漲）。3 家分析師公司在去年報告了評級。
What is the most recent analyst rating for Lantern Pharma (LTRN)?
燈籠製藥（LTRN）的最新分析師評級為何？
The latest analyst rating for Lantern Pharma (NASDAQ: LTRN) was provided by EF Hutton, and Lantern Pharma maintained their buy rating.
燈籠製藥公司（納斯達克股票代碼：LTRN）的最新分析師評級由 EF 赫頓提供，燈籠製藥維持其買入評級。
When is the next analyst rating going to be posted or updated for Lantern Pharma (LTRN)?
燈籠製藥（LTRN）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lantern Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lantern Pharma was filed on February 15, 2023 so you should expect the next rating to be made available sometime around February 15, 2024.
分析師在進行了廣泛的研究後獲得股票評級，其中包括查看公共財務報表，與 Lantern Pharma 的高管和客戶交談以及收聽財報電話會議。大多數分析師每三個月這樣做一次，因此您應該每年每家公司獲得 4 個評級。燈籠製藥的最後一個評級提交二月 15, 2023 所以你應該期望下一個評級將在二月左右的某個時候提供 15, 2024.
Is the Analyst Rating Lantern Pharma (LTRN) correct?
分析師評級燈籠製藥（LTRN）是否正確？
While ratings are subjective and will change, the latest Lantern Pharma (LTRN) rating was a maintained with a price target of $0.00 to $11.00. The current price Lantern Pharma (LTRN) is trading at is $5.22, which is within the analyst's predicted range.
雖然評級是主觀的並且會發生變化，但最新的 Lantern 製藥（LTRN）評級維持，目標價格為 0.00 美元至 11.00 美元。目前的價格燈籠製藥 (LTRN) 交易在 $5.22, 這是分析師的預測範圍內.
